Detailing Financial Links of Doctors and Drug Makers

The New York Times reports that a new federal reporting requirement shows that pharmaceutical and device makers paid doctors roughly $380 million in speaking and consulting fees during a five-month period last year. The data shed new light on the often murky financial ties between physicians and the health care industry. From August to December 2013, drug and device companies made 4.4 million payments to more than half a million health care professionals and teaching hospitals — adding up to about $3.5 billion.